The HIV protease inhibitor ritonavir blocks osteoclastogenesis and function by impairing RANKL-induced signaling
J. Clin. Invest. Michael W.-H. Wang, et al. 114:206
doi:10.1172/JCI15797 [Go to this article.]

Problems with a PDF?